Renal Cancer - Results from #320

Effect of Perioperative Blood Transfusion on Prognosis after Radical Resection in Patients with Non-Metastatic Renal Cell Carcinoma: A Retrospective Analysis. June 7, 2024

Relevance of Positive Surgical Margins in Localized Renal Cell Carcinoma After Surgical Resection: Predictive Factors and Survival Implications. June 7, 2024

Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma. June 6, 2024

Racial and Ethnic Disparities in Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Receiving Immunotherapy. June 6, 2024

Clinical T1/2 renal cell carcinoma: multiparametric dynamic contrast-enhanced MRI features-based model for the prediction of individual adverse pathology. June 5, 2024

Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: a review on behalf of the CC AFU. June 5, 2024

First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany. June 4, 2024

Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups. June 4, 2024

Current surgical approaches to pediatric renal tumors. June 3, 2024

Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. June 3, 2024

A Model to Predict Prognosis of Renal Cell Clear Cell Carcinoma Based on 3 Angiogenesis-related Long Non-coding RNAs. June 3, 2024

Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma. May 31, 2024

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial. May 31, 2024

Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review. May 31, 2024

Update on Renal Cell Carcinoma Diagnosis with Novel Imaging Approaches. May 30, 2024

CD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway. May 30, 2024

Characteristics, aetiology and implications for management of multiple primary renal tumours: a systematic review. May 30, 2024

Preoperative Super-Selective Embolization versus "On-Clamp" Laparoscopic Partial Nephrectomy for T1 Renal Tumors- A Prospective Randomized Study. May 29, 2024

Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration. May 29, 2024

Utility of PSMA PET/CT in Staging and Restaging of Renal Cell Carcinoma: A Systematic Review and Metaanalysis. May 29, 2024

Page 17 of 456